A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
As compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability. Semagacestat was...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 1,183
- Institution
- General Department of Preventive Medicine
External Links
Identifiers
- ORCID
- 0000-0003-3207-1295
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.